Study of PD-1 Antibody and Bevacizumab in the Treatment of High-risk GTN After Combined Chemotherapy
Clinical trial NCT04812002 · UNKNOWN
Trial details
- NCT number
- NCT04812002
- Sponsor
- Women's Hospital School Of Medicine Zhejiang University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-15
- Primary completion
- 2024-04-15
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.